IperionX Draws Pentagon Dollars and ADR Investors as Virginia Titanium Plant Hits 24/ 7 Rhythm

Bank of New York Mellon lifts stake to 21.18% as IperionX ramps titanium production for defense and aerospace, despite stock falling to oversold levels.

The US push to onshore critical mineral supply chains is reshaping the shareholder register at IperionX. Bank of New York Mellon has lifted its stake in the titanium group to 21.18%, up from 20.02% in a disclosure dated 13 May 2026. The move reflects greater use of the company’s American Depositary Receipts on the Nasdaq rather than a single aggressive buyer, but it nonetheless signals how the story is being framed in US markets: less a pure mining or technology play and more a domestic supply-chain hedge.

That repositioning aligns with a flurry of operational milestones. IperionX’s Virginia powder plant shifted to continuous 24/7 production during the March quarter, moving out of commissioning and into steady output. Current capacity stands at roughly 50 tonnes of titanium powder per year, with management targeting 200 tonnes by the end of 2026. Additional high-performance equipment, including a next-generation continuous furnace, is being installed to support the ramp. Longer term, the company aims for 1,400 tonnes a year by mid-2027 and more than 10,000 tonnes annually by 2030.

Government backing provides the financial momentum. The US Department of Defense has awarded IperionX $47.1 million through its IBAS programme, a pot that includes a $12.7 million grant announced recently for local titanium production. The US Export-Import Bank has signalled interest in a separate $11.5 million financing package. At the end of the March quarter the company held $48.2 million in cash, with a further $42.1 million in committed government funding on top. The combined war chest is earmarked for expanding capacity and advancing the Titan Critical Minerals Project in Tennessee, one of the largest permitted titanium and rare earth deposits in North America. A definitive feasibility study is due in the second quarter of 2026.

Defence and aerospace customers are already lining up. IperionX received a prototype order from American Rheinmetall for components bound for the US Army, and it is supplying titanium parts to the US Navy through a tie?up with Carver Pump. Civilian partnerships broaden the base: GKN Aerospace is taking high-performance titanium products, Aperam is co?building a fully recycled supply chain, and Heroux?Devtek is developing recycling solutions for aviation. The company’s patented HAMR and HSPT technologies allow it to produce powder from either recycled scrap or domestic mineral feedstocks, a flexibility that resonates with policymakers keen to break dependence on imports from geopolitical rivals.

The stock’s recent performance presents a sharp contrast with the operational progress. At €3.48, the shares have tumbled well below the year’s high despite a still-robust 86% gain over the past twelve months. The relative strength index has sunk to 14.6, a reading that typically flags extreme oversold conditions. Analysts remain broadly bullish, with the majority rating the stock a buy and pointing to the $1.4 billion market cap as leaving room for upside if the political and contract tailwinds hold.

Management appears to be voting with its wallet. Over the past three months net insider buying has totalled $2.57 million, with the chief executive alone purchasing nearly $500,000 worth of shares. That level of insider conviction, combined with $47.1 million of DoD backing and a plant now running around the clock, gives IperionX an unusually strong foundation for a company still scaling its core technology. The ADR-driven increase in BNY Mellon’s position merely underscores that the narrative is shifting from speculative promise to industrial reality.